Missed Sun Pharma’s rally? Trend pause offers fresh buying chance, Ajit Mishra
“Sun Pharma stock has begun to move in line with other pharma majors, finally breaking out of its year-long consolidation phase. Traders can buy for a target of Rs 1990 in the next 2-4 months,” Ajit Mishra – SVP, Research, Religare Broking Ltd, said.
READ MORE:
Other Stocks Videos
'Tough times never last, tough nations do': Ambani seeks fresh RIL momentum after Rs 1.5 lakh cr...
$320 billion danger: Why 70 EM funds still remain underweight on India
RIL AGM 2026: Date, Time & 4 Big Things to Watch (Jio IPO, Retail, Energy)
SpaceX IPO LIVE | Elon Musk becomes world's first trillionaire as company makes historic debut
SEBI unveils Pilot DLT tokenisation project as risk evaluation process continues